Maternal and Infant Syphilis Prevention Act

[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [H.R. 3866 Introduced in House (IH)] <DOC> 119th CONGRESS 1st Session H. R. 3866 To require the Secretary of Health and Human Services to issue guidance on best practices for screening and treatment of congenital syphilis under Medicaid and the Children's Health Insurance Program, and for other purposes. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES June 10, 2025 Mr. Ciscomani (for himself and Ms. Stansbury) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on Natural Resources, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned _______________________________________________________________________ A BILL To require the Secretary of Health and Human Services to issue guidance on best practices for screening and treatment of congenital syphilis under Medicaid and the Children's Health Insurance Program, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Maternal and Infant Syphilis Prevention Act''. SEC. 2. FINDINGS. Congress finds the following: (1) In 2023, there were 209,253 cases of syphilis in the United States, the highest number since 1950. This represents an 80 percent increase since 2018 and continuing a decades-long upward trend. (2) Untreated, syphilis can seriously damage the heart and brain and can cause blindness, deafness, and paralysis. (3) The increased rise in syphilis cases is causing the rise in congenital syphilis with more than 3,882, a 3 percent increase from 2022, resulting in 252 stillbirths and 27 infant deaths. The cases are more than 10 times the number diagnosed in 2012. (4)